Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 372 Neoplasms 263 Prostatic Neoplasms 188 Lung Neoplasms 137 Colorectal Neoplasms 128 Head and Neck Neoplasms 76 Colonic Neoplasms 67 Pancreatic Neoplasms 63 Carcinoma, Non-Small-Cell Lung 63 Carcinoma, Hepatocellular 61 Uterine Cervical Neoplasms 57 Multiple Myeloma 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 53 Neoplasm Metastasis 51 Leukemia, Myeloid, Acute 50 Brain Neoplasms 48 Liver Neoplasms 44 Rectal Neoplasms 42 Melanoma 42 Motor Activity 41 Lymphoma, Non-Hodgkin 41 Lymphoma 39 Leukemia 38 Pain 37 Ovarian Neoplasms 36 Hodgkin Disease 36 Fatigue 34 Depression 34 Barrett Esophagus 34 Lymphoma, Follicular 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Has results × Hypersensitivity × Clear all

NCT02835625 2024-08-28

TOBE

Norwegian Institute of Public Health

Phase NA Completed

29,453 enrolled 15 charts

Breast Neoplasms, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡